ISPOR - PCN83 Cost-Effectiveness Analysis of Combination Therapies Including Class II Anticancer Drug for Advanced or Metastatic Gastric Cancer

Full Text

PCN83 Cost-Effectiveness Analysis of Combination Therapies Including Class II Anticancer Drug for Advanced or Metastatic Gastric Cancer

Abstract

Authors

J.Y. Oh E.K. Lee

Back to Volume 14, Issue 7

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now